Santen Pharmaceutical Co's total assets for Q2 2026 were ¥389.14B, a decrease of -4.65% from the previous quarter. JP:4536 total liabilities were ¥115.53B for the fiscal quarter, a -9.68% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.